Shanghai Fosun Pharmaceutical(Group) Co.,Ltd.’s Net Profit Dropped 34.2% in First Quarter of 2022

Shanghai Fosun Pharmaceutical(Group) Co.,Ltd. (上海复星医药(集团)股份有限公司) (600196.SH) reported a net profit of 644.3 million yuan in the first quarter of 2022, down 34.2% year-on-year.

Meanwhile, the company posted 10.4 billion yuan in revenue, up 28.9% year-on-year.

At the end of the reporting period, it had 95.8 billion yuan in total assets and 48 billion yuan in total liabilities, with a liability-to-asset ratio of 50.1%.